1. Home
  2. KBR vs RGEN Comparison

KBR vs RGEN Comparison

Compare KBR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBR
  • RGEN
  • Stock Information
  • Founded
  • KBR 1901
  • RGEN 1981
  • Country
  • KBR United States
  • RGEN United States
  • Employees
  • KBR N/A
  • RGEN N/A
  • Industry
  • KBR Military/Government/Technical
  • RGEN Medical/Dental Instruments
  • Sector
  • KBR Industrials
  • RGEN Health Care
  • Exchange
  • KBR Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • KBR 6.3B
  • RGEN 8.0B
  • IPO Year
  • KBR 2006
  • RGEN N/A
  • Fundamental
  • Price
  • KBR $47.94
  • RGEN $123.57
  • Analyst Decision
  • KBR Buy
  • RGEN Buy
  • Analyst Count
  • KBR 7
  • RGEN 12
  • Target Price
  • KBR $68.33
  • RGEN $170.40
  • AVG Volume (30 Days)
  • KBR 1.4M
  • RGEN 787.0K
  • Earning Date
  • KBR 07-23-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • KBR 1.38%
  • RGEN N/A
  • EPS Growth
  • KBR N/A
  • RGEN N/A
  • EPS
  • KBR 2.98
  • RGEN N/A
  • Revenue
  • KBR $7,979,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • KBR $14.27
  • RGEN $13.93
  • Revenue Next Year
  • KBR $8.57
  • RGEN $14.35
  • P/E Ratio
  • KBR $16.10
  • RGEN N/A
  • Revenue Growth
  • KBR 12.84
  • RGEN 4.88
  • 52 Week Low
  • KBR $43.89
  • RGEN $102.97
  • 52 Week High
  • KBR $72.60
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • KBR 33.76
  • RGEN 48.29
  • Support Level
  • KBR $47.69
  • RGEN $115.86
  • Resistance Level
  • KBR $49.47
  • RGEN $126.61
  • Average True Range (ATR)
  • KBR 1.25
  • RGEN 4.43
  • MACD
  • KBR -0.45
  • RGEN -0.07
  • Stochastic Oscillator
  • KBR 13.72
  • RGEN 42.95

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: